140 related articles for article (PubMed ID: 11124591)
21. Lipid peroxidation on dialysis membranes.
Zima T; Haragsim L; Stípek S; Bártová V; Nĕmecek K
Biochem Mol Biol Int; 1993 Mar; 29(3):531-7. PubMed ID: 8485468
[TBL] [Abstract][Full Text] [Related]
22. [Levels of serum ascorbate and its metabolites in hemodialysis patients].
Hirano H; Tone Y; Otani H; Oya M; Kimura K; Saika Y; Fujii R; Mune M; Ichinose M; Yukawa S
Nihon Jinzo Gakkai Shi; 2004 Jul; 46(5):426-33. PubMed ID: 15446598
[TBL] [Abstract][Full Text] [Related]
23. Trace elements and lipid peroxidation in uremic patients on hemodialysis.
Lin TH; Chen JG; Liaw JM; Juang JG
Biol Trace Elem Res; 1996 Mar; 51(3):277-83. PubMed ID: 8727675
[TBL] [Abstract][Full Text] [Related]
24. Effect of hemodialysis on the deformability and lipid peroxidation of erythrocytes in chronic renal failure.
Szikszai Z; Ujhelyi L; Imre SG
Clin Hemorheol Microcirc; 2003; 28(4):201-7. PubMed ID: 12897411
[TBL] [Abstract][Full Text] [Related]
25. Plasma phosphatidylcholine hydroperoxide as a new marker of oxidative stress in alcoholic patients.
Adachi J; Matsushita S; Yoshioka N; Funae R; Fujita T; Higuchi S; Ueno Y
J Lipid Res; 2004 May; 45(5):967-71. PubMed ID: 14754913
[TBL] [Abstract][Full Text] [Related]
26. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
[TBL] [Abstract][Full Text] [Related]
27. Oxidative stress markers in pre-uremic patients.
Annuk M; Fellström B; Akerblom O; Zilmer K; Vihalemm T; Zilmer M
Clin Nephrol; 2001 Oct; 56(4):308-14. PubMed ID: 11680661
[TBL] [Abstract][Full Text] [Related]
28. Lipoperoxidation and hemodialysis.
Ramos R; Martínez-Castelao A
Metabolism; 2008 Oct; 57(10):1369-74. PubMed ID: 18803940
[TBL] [Abstract][Full Text] [Related]
29. [The influence of renal failure and renal replacement therapy on the activity of erythrocyte sodium-proton exchanger].
Kwiatkowska E
Ann Acad Med Stetin; 2004; 50(1):25-33. PubMed ID: 16871741
[TBL] [Abstract][Full Text] [Related]
30. Age-related increases in plasma phosphatidylcholine hydroperoxide concentrations in control subjects and patients with hyperlipidemia.
Kinoshita M; Oikawa S; Hayasaka K; Sekikawa A; Nagashima T; Toyota T; Miyazawa T
Clin Chem; 2000 Jun; 46(6 Pt 1):822-8. PubMed ID: 10839771
[TBL] [Abstract][Full Text] [Related]
31. The effect of hemodialysis on accelerated atherosclerosis in diabetic patients: correlation of carotid artery intima-media thickness with oxidative stress.
Dursun B; Dursun E; Suleymanlar G; Ozben B; Capraz I; Apaydin A; Ozben T
J Diabetes Complications; 2009; 23(4):257-64. PubMed ID: 18413174
[TBL] [Abstract][Full Text] [Related]
32. Oxidative damage during hemodialysis using a vitamin-E-modified dialysis membrane: a preliminary characterization.
Buoncristiani U; Galli F; Rovidati S; Albertini MC; Campus G; Canestrari F
Nephron; 1997; 77(1):57-61. PubMed ID: 9380239
[TBL] [Abstract][Full Text] [Related]
33. No direct evidence of increased lipid peroxidation in hemodialysis patients.
Banni S; Lucchi L; Baraldi A; Botti B; Cappelli G; Corongiu F; Dessi MA; Tomasi A; Lusvarghi E
Nephron; 1996; 72(2):177-83. PubMed ID: 8684523
[TBL] [Abstract][Full Text] [Related]
34. Leukocyte activation markers and oxidative status in chronic kidney disease.
Carollo C; Lo Presti R; Caimi G
Minerva Urol Nefrol; 2013 Mar; 65(1):69-76. PubMed ID: 23538312
[TBL] [Abstract][Full Text] [Related]
35. Vitamin E, lipid profile, and peroxidation in hemodialysis patients.
Galli F; Varga Z; Balla J; Ferraro B; Canestrari F; Floridi A; Kakuk G; Buoncristiani U
Kidney Int Suppl; 2001 Feb; 78():S148-54. PubMed ID: 11169001
[TBL] [Abstract][Full Text] [Related]
36. Superoxide anion generation, erythrocytes superoxide dismutase activity, and lipid peroxidation during hemoperfusion and hemodialysis in chronic uremic patients.
Trznadel K; Pawlicki L; Kedziora J; Luciak M; Błaszczyk J; Buczyński A
Free Radic Biol Med; 1989; 6(4):393-7. PubMed ID: 2540072
[TBL] [Abstract][Full Text] [Related]
37. Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient.
Miyata T; van Ypersele de Strihou C; Imasawa T; Yoshino A; Ueda Y; Ogura H; Kominami K; Onogi H; Inagi R; Nangaku M; Kurokawa K
Kidney Int; 2001 Dec; 60(6):2351-9. PubMed ID: 11737610
[TBL] [Abstract][Full Text] [Related]
38. The influence of the hemodialysis treatment time under oxidative stress biomarkers in chronic renal failure patients.
Valentini J; Grotto D; Paniz C; Roehrs M; Burg G; Garcia SC
Biomed Pharmacother; 2008; 62(6):378-82. PubMed ID: 18166291
[TBL] [Abstract][Full Text] [Related]
39. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
[TBL] [Abstract][Full Text] [Related]
40. Protein oxidation in chronic kidney disease.
Caimi G; Carollo C; Hopps E; Montana M; Lo Presti R
Clin Hemorheol Microcirc; 2013; 54(4):409-13. PubMed ID: 23719419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
